Allergan, Lyndra collaborate on once-weekly AD therapeutics
Allergan PLC and Lyndra Inc. agreed to collaborate on the development of oral, once-weekly formulations of Allergan's existing Alzheimer's disease (AD) therapeutics.
- Controlled Release
- Drug Delivery
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.